MAMEM Phase II Trials now moved to the cohort of Parkinson Disease
After having all 10 MAMEM systems installed in the home environment of subjects with Neuro-muscular disorders for one month, we …

After having all 10 MAMEM systems installed in the home environment of subjects with Neuro-muscular disorders for one month, we …
MAMEM has taken-up the quite challenging and ambitious goal of taking the developed system to the home environment of our …
We are glad to announce that the dataset from the first phase of MAMEM trials is now public. EEG, GSR, …
A video that illustrates the key characteristics of MAMEM, describing in simple terms the main goals and achievements of our …
MAMEM participated in the event of National Day against Parkinson Disease, which was held in Thessaloniki, Greece by the National …
In the occasion of the international day for Parkinson’s disease, representatives of MAMEM will be at the booth in Aristotelous …
MAMEM was presented and discussed in Alzheimer’s Europe meeting in Luxemburg where Patient Organizations, Regulators, Pharmaceutical Companies related to neurodegenerative …
We are very pleased that our colleagues from Aristotle University of Thessaloniki (AUTH) got their scientific work “Parkinson’s Disease Impact …
Thirty five PD pts with a long experience in computer operation were included in the study. Their mean age was …